LEED and the Lab: A Case Study
Francis Cauffman Foley Hoffman, Ltd.
Roswell Park Cancer Institute and The New York Center
for Excellence in Bioinformatics are jointly building a 300,000
square foot state-of-the-art research facility. The case study will
demonstrate: 1) how LEED was applied to a research building
and 2) lessons from the design that are applicable to new pharmaceutical
and biotechnology facilities.
- A brief systematic description of how the design of a lab meets
current LEED requirements
- A brief description of LEED innovations
- A brief outline of concepts in and approaches to lab/bioinformatic
Multiple drivers are converging on the design of research facilities.
One the one hand, architects are being challenged to make the research
environment as safe and as conducive as possible to excellence in
research; on the other hand, there are the critical sustainability
issues central to Laboratories for the 21st Century (Labs21) and
the USGBC's LEED program. Surrounding of all this is the client's
demand to minimize cost and maximize benefit. The presentation will
touch on such Labs21 issues as minimizing the impact to the environment,
optimizing whole building modeling intent on improving building
efficiency, and sharing ideas on how to track and improve beneficial
is a Principal at Francis Cauffman Foley Hoffmann, Architects Ltd
, Philadelphia, where he serves as the Director of Science and Technology
Group which manages projects for academic, institutional, and pharmaceutical/biotechnology
clients. His primary responsibility is in laboratory planning, programming,
and design. He is currently working on several university projects
and has led strategic facilities planning initiatives and lab projects
for Biogen, Bristol-Myers Squibb, and Pfizer in the U.S. and UK.
Mr. Shoemaker has a Masters from Columbia University and a Bachelors
of Architecture and Fine Arts from Rhode Island School of Design.
He is also a LEED certified professional.